Friday, July 20, 2018

PNB, IOB, Andhra Bank, Corporation Bank, Allahabad Bank up 4-13% post capital infusion

Share price of PNB, IOB, Andhra Bank, Corporation Bank and Allahabad Bank reacted positively on the government capital infusion plan.

Under the capital infusion plan, these 5 PSU banks will get� Rs 11,336 crore from government as part of its Indradhanush scheme, which was unveiled in 2015.

This is the last tranche of infusion under the scheme.

Of the Rs 11,336 crore, Rs 2,816 crore will be infused in PNB, Rs 2,157 crore in IOB, Rs 2,019 crore in Andhra Bank, Rs 2,555 in Corporation Bank, and Rs 1,790 crore in Allahabad Bank.

related news Sintex Industries soars 9% after strong operational show in Q1 Movers & Shakers: Volumes of Magma Fincorp & Rajasthan Cylinders rose the most in last 5 days

In October last year, the government had announced a Rs 2.11 lakh crore recapitalisation plan, of which Rs 1.35 lakh crore was to be raised through recapitalisation bonds, while banks were required to raise the balance through share sales.

The two-year recapitalisation programme was aimed at helping state-run banks to deal with rising bad debts and spur credit growth.

Punjab National Bank was quoting at Rs 81.15, up 3.11 percent, Indian Overseas Bank was quoting at Rs 15.09, up 11.86 percent and Andhra Bank was quoting at Rs 32.20, up 3.87 percent.

Corporation Bank was quoting at Rs 28.55, up 7.74 percent and Allahabad Bank was quoting at Rs 43.40, up 2.72 percent on the BSE.

Posted by Rakesh Patil First Published on Jul 18, 2018 09:24 am

Thursday, July 19, 2018

Dow marks 4th straight gain as stocks finish broadly higher after Powell testimony

U.S. stock on Tuesday closed firmly higher and the technology-heavy Nasdaq notched a fresh record after Federal Reserve Chairman Jerome Powell indicated that the U.S. central bank would continue raising benchmark rates due the the health of the economy but would execute its monetary-policy strategy at a prudent pace. The Dow Jones Industrial Average DJIA, +0.22% closed up 0.2% at 25,119 (on a preliminary basis), marking its fourth straight positive finish in succession. The blue-benchmark's gains were buoyed by a rally in component Johnson & Johnson JNJ, +3.54% which reported second-quarter earnings and revenue that were better than expected. Shares of the consumer-goods company gained 3.5% and contributed the lion's share of the equity index's Tuesday advance. The S&P 500 index SPX, +0.40% closed up 0.4% at 2,809, while the Nasdaq Composite Index COMP, +0.63% booked an all-time closing high, with a gain of 0.6% at 7,855. Providing testimony in front of the Senate Banking Committee, Powell said the "best way forward is to keep gradually raising the federal-funds rate for now." He will appear before a House committee on Wednesday. Meanwhile, economic reports supported the upbeat mood amid second-quarter corporate results that have mostly come out better than expected. Industrial production rose 0.6% in June to more than offset a similarly sized decline in May, the Federal Reserve said Tuesday. That was a tick above the MarketWatch forecast.

var SA = SA || []; SA.push({ container: "#sa_calc_723", version: 1.1, data: { key: "npqzoaaw8ttdneqrelpmx2gdnehdyiog" } }); var smscript = document.createElement('script'); smscript.type = 'text/javascript'; smscript.async = true; smscript.src = 'https://smartasset.com/snippet.js'; var s = document.getElementsByTag

Friday, July 13, 2018

Top Safest Stocks To Invest In 2019

tags:SBLK,MGYR,ESP,LULU,PEG,  Today, I will show you how to take our very best investment ideas and make them 10 times better...   That's right. Using this simple strategy, I believe every individual investor managing less than $10 million can earn 50% a year in safe stocks. Returns at this level can transform your retirement... or even build generational wealth.   But this doesn't mean you have to buy risky stocks. And I'm not talking about anything expensive, difficult, or complex. I'm just talking about taking our best, safest ideas... and making one tiny adjustment.   It's something anyone can do. And it's easy.    Can you really make 50% a year?   Yes. In fact, it's almost certain that you will. I'm not talking about generating a little extra income. I'm talking about a way to turn our best ideas into absolute home runs. I'm talking about the best way to make a fortune in the stock market.

Top Safest Stocks To Invest In 2019: Star Bulk Carriers Corp.(SBLK)

Advisors' Opinion:
  • [By Max Byerly]

    Media headlines about Star Bulk Carriers (NASDAQ:SBLK) have trended somewhat negative recently, Accern reports. The research group identifies negative and positive media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Star Bulk Carriers earned a news impact score of -0.01 on Accern’s scale. Accern also gave news stories about the shipping company an impact score of 45.7096408743614 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Ethan Ryder]

    Star Bulk Carriers (NASDAQ: SBLK) and Gener8 Maritime (NYSE:GNRT) are both small-cap transportation companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends and profitability.

  • [By Motley Fool Staff]

    Star Bulk Carriers (NASDAQ:SBLK) Q1 2018 Earnings Conference CallJun. 12, 2018 11:00 a.m. ET

    Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Star Bulk Carriers (NASDAQ:SBLK) had its price target boosted by Morgan Stanley from $14.00 to $15.00 in a report issued on Wednesday morning. Morgan Stanley currently has an overweight rating on the shipping company’s stock.

Top Safest Stocks To Invest In 2019: Magyar Bancorp Inc.(MGYR)

Advisors' Opinion:
  • [By Ethan Ryder]

    Media headlines about Magyar Bancorp (NASDAQ:MGYR) have been trending somewhat positive on Friday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Magyar Bancorp earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned media headlines about the bank an impact score of 48.0770691063571 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Top Safest Stocks To Invest In 2019: Espey Mfg. & Electronics Corp.(ESP)

Advisors' Opinion:
  • [By Ethan Ryder]

    Espers (ESP) is a PoW/PoS coin that uses the HMQ1725 hashing algorithm. It was first traded on April 28th, 2016. Espers’ total supply is 21,802,827,290 coins. The Reddit community for Espers is /r/esperscoin and the currency’s Github account can be viewed here. Espers’ official Twitter account is @CryptoCoderz and its Facebook page is accessible here. Espers’ official website is espers.io.

  • [By Stephan Byrd]

    Espers (CURRENCY:ESP) traded up 5.2% against the US dollar during the one day period ending at 7:00 AM Eastern on May 28th. Espers has a market capitalization of $6.27 million and approximately $8,492.00 worth of Espers was traded on exchanges in the last 24 hours. One Espers coin can now be bought for about $0.0003 or 0.00000004 BTC on cryptocurrency exchanges including Livecoin and CoinExchange. During the last seven days, Espers has traded down 26.2% against the US dollar.

Top Safest Stocks To Invest In 2019: lululemon athletica inc.(LULU)

Advisors' Opinion:
  • [By John Ballard]

    I've selected three stocks that are in a solid position to ride this massive consumer shift to online and mobile shopping. These companies cover all the bases of e-commerce. More people are choosing to pay for online orders with PayPal Holdings (NASDAQ:PYPL),�FedEx (NYSE:FDX) is there to ship those online orders, and lululemon athletica (NASDAQ:LULU) has got one of the top brands in apparel that is enjoying strong momentum right now thanks to its booming online business.

  • [By ]

    In the mid-level, Boss said that Urban Outfitters (URBN) is recovering, along with Kohl's Stores (KSS) . He also liked PVH (PVH) and Lululemon Athletica (LULU) .

  • [By Demitrios Kalogeropoulos]

    Just about everything is going right for Lululemon Athletica�(NASDAQ:LULU) these days. The yoga-inspired apparel specialist isn't just raising the bar on its key growth metrics -- it's also boosting profitability even as the business shifts toward the e-commerce channel.

  • [By Jeremy Bowman]

    Meanwhile, Under Armour's rivals like�Nike�(NYSE:NKE),�Adidas�(NasdaqOTC: ADDYY), and�lululemon athletica�(NASDAQ:LULU)�all performed well in the survey. Piper Jaffray found that Adidas was the fastest-growing brand in the survey, which follows Adidas's recent stock surge and sales and profit growth. Its Originals, or classic sneakers, like the Stan Smith and the Superstar were especially popular last year. The Superstar, in fact, was the No. 1-selling sneaker last year, according to NPD Group, dethroning Nike for the first time in more than a decade.��

Top Safest Stocks To Invest In 2019: Public Service Enterprise Group Incorporated(PEG)

Advisors' Opinion:
  • [By Stephan Byrd]

    FDx Advisors Inc. lowered its stake in shares of Public Service Co. (NYSE:PEG) by 15.8% during the 1st quarter, HoldingsChannel.com reports. The firm owned 36,891 shares of the utilities provider’s stock after selling 6,935 shares during the quarter. FDx Advisors Inc.’s holdings in Public Service were worth $1,853,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Norinchukin Bank The raised its position in Public Service Enterprise Group (NYSE:PEG) by 15.8% during the first quarter, according to its most recent filing with the SEC. The firm owned 49,652 shares of the utilities provider’s stock after purchasing an additional 6,793 shares during the period. Norinchukin Bank The’s holdings in Public Service Enterprise Group were worth $2,495,000 as of its most recent filing with the SEC.

  • [By Max Byerly]

    Media headlines about Public Service (NYSE:PEG) have trended somewhat positive recently, according to Accern. The research firm identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Public Service earned a media sentiment score of 0.04 on Accern’s scale. Accern also gave headlines about the utilities provider an impact score of 46.5923185859882 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Public Service Enterprise Group (NYSE:PEG) from a hold rating to a buy rating in a research report report published on Tuesday morning.

Tuesday, July 10, 2018

2 Surprising Trade-War Buys for 10.6% Dividends and Upside

&l;p&g;&l;img class=&q;dam-image getty size-large wp-image-991009186&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/991009186/960x0.jpg?fit=scale&q; data-height=&q;703&q; data-width=&q;960&q;&g; (Photo by Mark Wilson/Getty Images)

If you&a;rsquo;ve been holding cash and waiting for the perfect buying opportunity, your time to strike is now.

Because a &l;i&g;very&l;/i&g; predictable market pattern has been repeating itself in the last few months&a;mdash;and is about to do so again.

Let&a;rsquo;s recap.

First, there was the euphoria of January, followed by the panic selling of February and March, followed by renewed confidence in April, May and early June. But then, just a couple weeks ago, the market went back to panic mode. The reason is familiar: the looming trade war.

Back in February and March, President Trump threatened tariffs on goods from China, the EU and even Canada. But then these tensions eased in April and May, so investors went back to focusing on earnings&a;mdash;only to &l;i&g;again &l;/i&g;go back to the fear of a damaging trade war.

This pattern has become predictable enough to become a profit-making opportunity for you and me. Because, whether there is a trade war or not, its impact on the S&a;amp;P 500 is much less than the fear-mongers would have you believe.

Better yet, this fear has handed us 2 deeply discounted funds that are terrific buys now. Before I show them to you, let&a;rsquo;s dig into why now is the time to pick them up.

&l;b&g;The S&a;amp;P&a;rsquo;s Dirty Secret: Overseas Sales Are Already a Non-Factor&l;/b&g;

The idea that a trade war would hurt US companies, and therefore US stock prices, makes sense on the surface: it would raise the prices&a;mdash;and cut the sales&a;mdash;of American goods abroad.

But dig deeper and you&a;rsquo;ll quickly see that it&a;rsquo;s not that simple. In 2014, the S&a;amp;P 500 got 47.8% of its combined revenue from abroad. That fell by 7.3% in 2015 and fell again, by 2.5% in 2016, according to S&a;amp;P Dow Jones Indices.

Although sales abroad fell during this time, stocks rose solidly, reaching their &l;i&g;highest&l;/i&g; point in the three-year period when overseas sales were at their &l;i&g;lowest&l;/i&g; point.

This amounts to a 9.5% annualized return, far above the 7.5%-ish average return the stock market usually gives investors. And don&a;rsquo;t forget that this happened when foreign sales were &l;i&g;falling&l;/i&g; for American companies.

The reason why this happened is simple, and often overlooked: domestic US sales were rising enough to compensate for the fall in foreign sales, and earnings growth was soaring thanks to improved productivity in the US.

These trends have improved in the last two years&a;mdash;and, in fact, 2018 is on track to see the highest revenue growth in over a decade for S&a;amp;P 500 companies, even when accounting for any potential loss of foreign sales. Meantime, the US dollar is getting stronger, US employment and wage growth is on the rise and consumers are more confident&a;mdash;and thus willing to spend more.

Which means every selloff in light of trade war fears is a big buying opportunity.

&l;b&g;2 Trade War Winners&a;mdash;From the CUBA to the USA&l;/b&g;

So what are the funds to consider in this counter-intuitive trade-war game of chicken?

The first one will shock you: the &l;b&g;Herzfeld Caribbean Basin Fund&l;/b&g;, a fund that is designed to give investors exposure to Cuba.

I&a;rsquo;ve been critical of this fund in the past, because it simply does &l;i&g;not &l;/i&g;do what it claims. But that&a;rsquo;s a virtue now. CUBA&a;rsquo;s largest holdings are actually American companies that theoretically would benefit the most from Cuba opening up to capitalism, stocks like &l;b&g;Royal Caribbean Cruise Lines, Seaboard Corp.&l;/b&g; and &l;b&g;Lennar Corp. &l;/b&g;

Since these firms are well positioned to benefit from the rising dollar, which will give domestic Americans more purchasing power (and Americans are these companies&a;rsquo; biggest customers), CUBA is actually chock full of companies poised to benefit from America&a;rsquo;s fundamentally strong economy.

But investors have overlooked that and discounted CUBA based solely on its name. That&a;rsquo;s why its discount to net asset value (NAV) has widened to its widest point in three years and is far below its 11.3% average discount in the last decade!

There&a;rsquo;s just one snag with CUBA&a;mdash;its dividend is irregular and tiny (its current yield is less than 2%).

So if you want the same play but a bigger income stream, you might want to consider the &l;b&g;Liberty All-Star Equity Fund &l;/b&g;instead.

From its name and ticker, you can tell that USA is very different from CUBA&a;mdash;at least when it comes to how the fund managers market it to potential investors.

In reality, though, both are heavily invested in companies that profit from a stronger American consumer. USA&a;rsquo;s top holdings include &l;b&g;Visa, Bank of America, PayPal, Home Depot&l;/b&g; and &l;b&g;Capital One Financial&l;/b&g;&a;mdash;in other words, firms heavily exposed to the American economy that won&a;rsquo;t suffer big losses if the rest of the world buys fewer American products.

And, unlike CUBA, USA has a regular and high-yielding dividend, at 10.6% currently.

There&a;rsquo;s another nice thing about USA&a;mdash;although it has a huge yield versus the benchmark &l;b&g;SPDR S&a;amp;P 500 ETF,&l;/b&g; which pays out a measly 1.8%, USA has beaten the index by a wide margin&a;mdash;proving that its managers are making wise and profitable stock picks.

Possibly, this market outperformance (which wasn&a;rsquo;t there before 2014, when US sales abroad weren&a;rsquo;t dropping as dramatically) is the result of USA&a;rsquo;s focus on, well, the USA&a;mdash;and that may mean that it will continue to outperform if a trade war is unavoidable.

Disclosure: none

&l;!--donotpaginate--&g;&l;/p&g;

Monday, July 9, 2018

Zacks Investment Research Downgrades Playags (AGS) to Sell

Playags (NYSE:AGS) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a note issued to investors on Wednesday.

According to Zacks, “PlayAGS, Inc. is a designer and supplier of electronic gaming machines and other products and services for the gaming industry. The company’s product line-up includes Class III EGMs for commercial and Native American casinos, video bingo machines for select international markets, table game products and interactive social casino products. PlayAGS, Inc. is headquartered in Las Vegas, Nevada. “

Get Playags alerts:

Several other analysts have also weighed in on the company. ValuEngine upgraded Playags from a “hold” rating to a “buy” rating in a research report on Thursday, May 17th. Bank of America raised their price objective on Playags from $24.00 to $26.00 and gave the stock a “buy” rating in a research report on Friday, May 4th. Deutsche Bank raised their price objective on Playags from $23.00 to $25.00 and gave the stock a “buy” rating in a research report on Thursday, March 15th. Finally, Stifel Nicolaus raised their price objective on Playags from $24.00 to $25.00 and gave the stock a “buy” rating in a research report on Thursday, March 15th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $24.75.

Playags opened at $28.31 on Wednesday, Marketbeat reports. The company has a current ratio of 2.91, a quick ratio of 2.08 and a debt-to-equity ratio of 3.37. The firm has a market cap of $976.92 million and a price-to-earnings ratio of -14.59. Playags has a fifty-two week low of $16.66 and a fifty-two week high of $28.49.

Playags (NYSE:AGS) last released its earnings results on Thursday, May 3rd. The company reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.21) by $0.02. The company had revenue of $64.86 million for the quarter, compared to analyst estimates of $60.83 million. equities analysts expect that Playags will post -0.26 EPS for the current fiscal year.

A number of institutional investors have recently made changes to their positions in AGS. Caledonia Private Investments Pty Ltd acquired a new stake in Playags in the first quarter valued at approximately $37,447,000. Park West Asset Management LLC purchased a new position in shares of Playags during the first quarter valued at approximately $18,514,000. BlackRock Inc. purchased a new position in shares of Playags during the first quarter valued at approximately $13,988,000. Principal Financial Group Inc. purchased a new position in shares of Playags during the first quarter valued at approximately $12,030,000. Finally, RWC Asset Management LLP purchased a new position in shares of Playags during the first quarter valued at approximately $7,052,000.

About Playags

PlayAGS, Inc designs and supplies electronic gaming machines (EGMs), and other products and services for the gaming industry in the United States and internationally. It operates in three segments: EGMs, Table Products, and Interactive. The EGM segment offers various video slot titles, which include ICON, Halo, Colossal Diamonds cabinet, and Orion; and conversion kits that allow existing game titles to be converted to other game titles offered within that operating platform.

Get a free copy of the Zacks research report on Playags (AGS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Playags (NYSE:AGS)

Saturday, July 7, 2018

Spectrum Pharmaceuticals (SPPI) Rating Lowered to Hold at Zacks Investment Research

Spectrum Pharmaceuticals (NASDAQ:SPPI) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Thursday.

According to Zacks, “Spectrum Pharma is expected to file a BLA for its lead pipeline candidate, Rolontis in 2018. A potential approval will boost the prospect of the company. However, Spectrum has faced regulatory setbacks in the past including a CRL for Qapzola (bladder cancer) in the United States. Additional regulatory/development setbacks could affect the stock. However, out-licensing agreements for a number of products will allow Spectrum to focus on the development of its pipeline candidates. Spectrum’s shares have outperformed the industry in past one year. However, Spectrum's low product sales remain a cause of concern. Moreover, gaining market share is challenging for Spectrum as it competes with several companies with greater financial strength.”

Get Spectrum Pharmaceuticals alerts:

SPPI has been the subject of several other reports. TheStreet lowered Spectrum Pharmaceuticals from a “c-” rating to a “d+” rating in a research report on Friday, March 16th. ValuEngine raised Spectrum Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd. BidaskClub lowered Spectrum Pharmaceuticals from a “hold” rating to a “sell” rating in a research report on Wednesday, April 4th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $33.00 target price on shares of Spectrum Pharmaceuticals in a research report on Friday, June 29th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Spectrum Pharmaceuticals has an average rating of “Buy” and an average price target of $27.20.

Shares of Spectrum Pharmaceuticals opened at $22.14 on Thursday, MarketBeat.com reports. The firm has a market cap of $2.22 billion, a P/E ratio of -20.44 and a beta of 1.98. Spectrum Pharmaceuticals has a 12-month low of $7.12 and a 12-month high of $23.50.

Spectrum Pharmaceuticals (NASDAQ:SPPI) last announced its earnings results on Thursday, May 3rd. The biotechnology company reported ($0.16) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.35) by $0.19. The business had revenue of $30.50 million during the quarter, compared to analyst estimates of $25.68 million. Spectrum Pharmaceuticals had a negative return on equity of 29.47% and a negative net margin of 64.39%. Spectrum Pharmaceuticals’s revenue for the quarter was up 4.8% compared to the same quarter last year. During the same period last year, the company earned ($0.14) EPS. equities research analysts anticipate that Spectrum Pharmaceuticals will post -0.91 earnings per share for the current year.

In other Spectrum Pharmaceuticals news, Director Rajesh C. Md Shrotriya sold 12,300 shares of the stock in a transaction dated Monday, April 9th. The stock was sold at an average price of $15.01, for a total transaction of $184,623.00. Following the completion of the sale, the director now directly owns 200,652 shares in the company, valued at approximately $3,011,786.52. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Rajesh C. Md Shrotriya sold 30,000 shares of the stock in a transaction dated Wednesday, April 11th. The stock was sold at an average price of $20.30, for a total value of $609,000.00. Following the sale, the director now owns 200,652 shares of the company’s stock, valued at $4,073,235.60. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 646,417 shares of company stock valued at $11,440,813. 9.35% of the stock is owned by corporate insiders.

Institutional investors have recently modified their holdings of the business. Teacher Retirement System of Texas acquired a new stake in shares of Spectrum Pharmaceuticals in the 4th quarter valued at about $541,000. California Public Employees Retirement System grew its stake in shares of Spectrum Pharmaceuticals by 31.1% in the 4th quarter. California Public Employees Retirement System now owns 204,113 shares of the biotechnology company’s stock valued at $3,868,000 after buying an additional 48,413 shares during the period. Swiss National Bank grew its stake in shares of Spectrum Pharmaceuticals by 7.3% in the 4th quarter. Swiss National Bank now owns 144,000 shares of the biotechnology company’s stock valued at $2,729,000 after buying an additional 9,800 shares during the period. Wells Fargo & Company MN grew its stake in shares of Spectrum Pharmaceuticals by 2.6% in the 4th quarter. Wells Fargo & Company MN now owns 973,812 shares of the biotechnology company’s stock valued at $18,454,000 after buying an additional 24,522 shares during the period. Finally, The Manufacturers Life Insurance Company grew its stake in shares of Spectrum Pharmaceuticals by 10.7% in the 4th quarter. The Manufacturers Life Insurance Company now owns 66,341 shares of the biotechnology company’s stock valued at $1,257,000 after buying an additional 6,396 shares during the period. Hedge funds and other institutional investors own 77.15% of the company’s stock.

About Spectrum Pharmaceuticals

Spectrum Pharmaceuticals, Inc develops and commercializes oncology and hematology drug products. The company markets six drug products, including FUSILEV for patients with metastatic colorectal cancer and rescue after high-dose methotrexate therapy in osteosarcoma, and to diminish toxicity and counteract the effects of impaired methotrexate elimination and of inadvertent overdosage of folic acid antagonists; FOLOTYN, a folate analogue metabolic inhibitor for peripheral T-cell lymphoma (PTCL); ZEVALIN injection for patients with B-cell non-Hodgkin's lymphoma; MARQIBO, a sphingomyelin/cholesterol liposome-encapsulated formulation for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia; BELEODAQ injection for PTCL; and EVOMELA for use as a conditioning treatment prior to autologous stem cell transplant in multiple myeloma patients.

Get a free copy of the Zacks research report on Spectrum Pharmaceuticals (SPPI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Thursday, July 5, 2018

Patron (PAT) Price Hits $0.0323 on Exchanges

Patron (CURRENCY:PAT) traded 2.8% lower against the US dollar during the 24-hour period ending at 0:00 AM E.T. on July 3rd. One Patron token can currently be purchased for about $0.0323 or 0.00000500 BTC on popular exchanges. During the last week, Patron has traded 4% higher against the US dollar. Patron has a total market capitalization of $7.43 million and $262,027.00 worth of Patron was traded on exchanges in the last day.

Here is how similar cryptocurrencies have performed during the last day:

Get Patron alerts: XRP (XRP) traded 5% lower against the dollar and now trades at $0.48 or 0.00007420 BTC. Ripple (XRP) traded 4.6% lower against the dollar and now trades at $0.45 or 0.00007633 BTC. Stellar (XLM) traded down 5.6% against the dollar and now trades at $0.21 or 0.00003169 BTC. IOTA (MIOTA) traded down 6.1% against the dollar and now trades at $1.13 or 0.00017411 BTC. Tether (USDT) traded up 0% against the dollar and now trades at $1.00 or 0.00015433 BTC. TRON (TRX) traded 5.4% lower against the dollar and now trades at $0.0382 or 0.00000591 BTC. NEO (NEO) traded 4% lower against the dollar and now trades at $36.23 or 0.00559942 BTC. Binance Coin (BNB) traded down 4% against the dollar and now trades at $14.08 or 0.00217551 BTC. VeChain (VET) traded 5.7% lower against the dollar and now trades at $2.62 or 0.00040563 BTC. Ontology (ONT) traded down 6.8% against the dollar and now trades at $5.04 or 0.00077852 BTC.

Patron Profile

Patron launched on February 25th, 2018. Patron’s total supply is 400,000,000 tokens and its circulating supply is 229,954,715 tokens. Patron’s official website is patron-ico.io.

Buying and Selling Patron

Patron can be purchased on the following cryptocurrency exchanges: HitBTC. It is usually not currently possible to purchase alternative cryptocurrencies such as Patron directly using U.S. dollars. Investors seeking to trade Patron should first purchase Ethereum or Bitcoin using an exchange that deals in U.S. dollars such as Gemini, Changelly or GDAX. Investors can then use their newly-acquired Ethereum or Bitcoin to purchase Patron using one of the exchanges listed above.

new TradingView.widget({ “height”: 400, “width”: 650, “symbol”: “PATUSD”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});